The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement
Conditions: Aortic Valve Stenosis; Heart Failure; Inotropic Agents; Safety Issues; Effect of Drug; Cardiac Event; Transcatheter Aortic Valve Replacement Interventions: Drug: Levosimendan; Other: Placebo Sponsors: China National Center for Cardiovascular Diseases; China International Medical Foundation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials